Chief Executive Officer
Olivier Brandicourt joined Sanofi in April 2015 as Chief Executive Officer.
Prior to joining the Group, Olivier Brandicourt was Chief Executive Officer of Bayer Healthcare AG (2013-2015). From 2000 through to 2013, as member of the Executive Leadership Team, he held a series of leadership positions at Pfizer, including President and General Manager of Global Primary Care and President and General Manager of the Emerging Markets and Established Products business units.
Dr. Brandicourt studied medicine in Paris where he specialized in Infectious Diseases and Tropical Medicine and holds a Master’s Degree in Biology and an Advanced Degree in Cellular and Immunological Pathophysiology.
In addition to his responsibilities at Sanofi, Dr. Brandicourt is Chairman of the Board of Management of the Pharmaceutical Research and Manufacturers of America (PhRMA), Vice-President of the European Federation of Pharmaceutical Industries and Associations (EFPIA), and an Honorary Fellow of the Royal College of Physicians in London.